Patent details
EP2547698 Title: METHODS OF DETERMINING SUSCEPTIBILITY OF TUMORS TO TYROSINE KINASE INHIBITORS
Basic Information
- Publication number:
- EP2547698
- PCT Application Number:
- PCT/US/2011/028415
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP117568220
- PCT Publication Number:
- WO/2011/115937
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS OF DETERMINING SUSCEPTIBILITY OF TUMORS TO TYROSINE KINASE INHIBITORS
- French Title of Invention:
- PROCÉDÉS DE DÉTERMINATION DE LA SENSIBILITÉ DE TUMEURS À DES INHIBITEURS DE LA TYROSINE KINASE
- German Title of Invention:
- VERFAHREN ZUR BESTIMMUNG DER EMPFINDLICHKEIT VON TUMOREN GEGEN TYROSINKINASEHEMMER
- SPC Number:
Dates
- Filing date:
- 14/03/2011
- Grant date:
- 29/07/2015
- EP Publication Date:
- 29/07/2015
- PCT Publication Date:
- 22/09/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/01/2013
- EP B1 Publication Date:
- 29/07/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 14/03/2016
- Expiration date:
- 14/03/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/03/2011
- Name:
- The Translational Genomics Research Institute
- Address:
- 445 N. 5th Street, Suite 600, Phoenix, Arizona 85004, United States (US)
Inventor
1
- Name:
- POLLOCK Pamela
- Address:
- Australia (AU)
2
- Name:
- BYRON Sara
- Address:
- United States (US)
Priority
- Priority Number:
- 313762 P
- Priority Date:
- 14/03/2010
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 14/705;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|